Both chambers approved the final version of an economic incentives bill, which lacked funds for a new cancer treatment center at UNC-Chapel Hill and a biopharmaceutical research facility at N.C. State University.
The economic incentives bill, which was nearly killed in a conference committee, was the last major item on the legislature's agenda before its adjournment early Friday.
"This has been a long and difficult bill for many of us," said Rep. Bill Owens, D-Pasquotank. "She was dead a couple times. We had to give her mouth to mouth and bring her back to life."
A week ago, N.C. Senate leaders inserted a provision in the economic incentives bill providing $130 million in funding for the cancer center. The provision was later scaled down to $6 million in startup funding before finally being eliminated Thursday in conference committee.
Rep. David Redwine, D-Brunswick, said many legislators opposed providing the $6 million for planning because doing so would have forced Gov. Mike Easley to trim additional money from other state agencies.
"The governor would have taken the money from somewhere, and we didn't want him to take it from education or health and human services," said Redwine, chairman of the House Appropriations Committee.
The economic incentives bill does include language authorizing planning and development of the UNC-CH cancer treatment center and a biopharmaceutical research facility.
"I'm delighted we at least have the reference to the biopharmaceutical center and the cancer center," said Sen. Howard Lee, D-Orange. "At least we have our foot in the door.
"Sometimes you have to take baby steps. This is a baby step."